30-09-2024 18:24
STADA Pymepharco is expanding to deliver “German standard” healthcare in Vietnam and to the world, driven by economic prosperity through innovation, business excellence, community wellbeing, and sustainable practices. Stéphane Jacqmin, executive vice president Emerging Markets at STADA Group, spoke to VIR’s Bich Thuy about the company's 35-year journey in the country, and its long-term vision.
21-08-2024 10:35
Generic drugmaker STADA announced the acquisition of Nizoral Cream from Janssen Pharmaceutica NV, a Johnson & Johnson company, in Vietnam and other markets on August 19.
10-08-2023 09:07
STADA and its Vietnamese affiliate Pymepharco have announced the establishment of its new head office in Ho Chi Minh City, paving the way for further expansion in Vietnam's healthcare market.
29-11-2022 18:31
Regional business executives of leading European corporations in various sectors met with Prime Minister Pham Minh Chinh at the Green Economy Forum and Exhibition (GEFE) 2022 on November 28 in Ho Chi Minh City.
30-06-2021 14:20
Dealmaking and investment in pharmaceutical and healthcare businesses are increasing in scope as investors are vying for the controlling stake of key players.
20-11-2020 20:59
Mergers and acquisitions in Vietnam’s healthcare and pharmaceutical sector in 2020 have been held up due to the global health crisis – but prospects remaining enticing thanks to new drivers of interest.